| Recognizing pitfalls in virtual screening: a critical review T Scior, A Bender, G Tresadern, JL Medina-Franco, K Martínez-Mayorga, ... Journal of chemical information and modeling 52 (4), 867-881, 2012 | 473 | 2012 |
| Preliminary screening of some tropical plants for anti-tyrosinase activity N Baurin, E Arnoult, T Scior, QT Do, P Bernard Journal of ethnopharmacology 82 (2-3), 155-158, 2002 | 257 | 2002 |
| How to recognize and workaround pitfalls in QSAR studies: a critical review T Scior, JL Medina-Franco, QT Do, K Martínez-Mayorga, JA Yunes Rojas, ... Current medicinal chemistry 16 (32), 4297-4313, 2009 | 240 | 2009 |
| Ethnopharmacology and bioinformatic combination for leads discovery: application to phospholipase A2 inhibitors P Bernard, T Scior, B Didier, M Hibert, JY Berthon Phytochemistry 58 (6), 865-874, 2001 | 166 | 2001 |
| Adenosine receptors and their modulators CE Müller, T Scior Pharmaceutica Acta Helvetiae 68 (2), 77-111, 1993 | 166 | 1993 |
| Synthesis and biological testing of purine derivatives as potential ATP-competitive kinase inhibitors SA Laufer, DM Domeyer, TRF Scior, W Albrecht, DRJ Hauser Journal of medicinal chemistry 48 (3), 710-722, 2005 | 131 | 2005 |
| Why antidiabetic vanadium complexes are not in the pipeline of “big pharma” drug research? A critical review T Scior, J Antonio Guevara-Garcia, QT Do, P Bernard, S Laufer Current medicinal chemistry 23 (25), 2874-2891, 2016 | 107 | 2016 |
| Isoniazid is not a lead compound for its pyridyl ring derivatives, isonicotinoyl amides, hydrazides, and hydrazones: a critical review T Scior, SJ Garces-Eisele Current medicinal chemistry 13 (18), 2205-2219, 2006 | 107 | 2006 |
| Scaffold diversity analysis of compound data sets using an entropy‐based measure JL Medina‐Franco, K Martínez‐Mayorga, A Bender, T Scior QSAR & Combinatorial Science 28 (11‐12), 1551-1560, 2009 | 93 | 2009 |
| Antitubercular Isoniazid and Drug Resistance of Mycobacterium tuberculosis — A Review T Scior, I Meneses Morales, SJ Garcés Eisele, D Domeyer, S Laufer Archiv der Pharmazie: An International Journal Pharmaceutical and Medicinal …, 2002 | 91 | 2002 |
| Are vanadium compounds drugable? Structures and effects of antidiabetic vanadium compounds: a critical review T Scior, A Guevara-García, P Bernard, QT Do, D Domeyer, S Laufer Mini reviews in medicinal chemistry 5 (11), 995-1008, 2005 | 66 | 2005 |
| Large compound databases for structure-activity relationships studies in drug discovery. T Scior, P Bernard, JL Medina-Franco, GM Maggiora Mini Reviews in Medicinal Chemistry 7 (8), 851-860, 2007 | 63 | 2007 |
| Prolyl isomerases in a minimal cell: Catalysis of protein folding by trigger factor from Mycoplasma genitalium H Bang, A Pecht, G Raddatz, T Scior, W Solbach, K Brune, A Pahl European Journal of Biochemistry 267 (11), 3270-3280, 2000 | 46 | 2000 |
| Application of drug repositioning strategy to TOFISOPAM P Bernard, C Dufresne-Favetta, P Favetta, QT Do, F Himbert, S Zubrzycki, ... Current medicinal chemistry 15 (30), 3196-3203, 2008 | 42 | 2008 |
| Antidiabetic Bis-Maltolato-OxoVanadium (IV): conversion of inactive trans-to bioactive cis-BMOV for possible binding to target PTP-1B T Scior, HG Mack, JAG García, W Koch Drug Design, Development and Therapy, 221-231, 2009 | 41 | 2009 |
| Reverse pharmacognosy: another way to harness the generosity of nature S Blondeau, QT Do, T Scior, P Bernard, L Morin-Allory Current pharmaceutical design 16 (15), 1682-1696, 2010 | 39 | 2010 |
| Reviewing and identifying amino acids of human, murine, canine and equine TLR4/MD-2 receptor complexes conferring endotoxic innate immunity activation by LPS/lipid A, or … T Scior, C Alexander, U Zaehringer Computational and structural biotechnology journal 5 (6), e201302012, 2013 | 37 | 2013 |
| 11-keto-β-boswellic acids prevent development of autoimmune reactions, insulitis and reduce hyperglycemia during induction of multiple low-dose streptozotocin (MLD-STZ … AM Shehata, L Quintanilla-Fend, S Bettio, J Jauch, T Scior, ... Hormone and Metabolic Research 47 (06), 463-469, 2015 | 34 | 2015 |
| Pharmacophore design of p38α MAP kinase inhibitors with either 2, 4, 5-trisubstituted or 1, 2, 4, 5-tetrasubstituted imidazole scaffold T Scior, D M Domeyer, K Cuanalo-Contreras, S A Laufer Current medicinal chemistry 18 (10), 1526-1539, 2011 | 34 | 2011 |
| Elucidating isoniazid resistance using molecular modeling HA Wahab, YS Choong, P Ibrahim, A Sadikun, T Scior Journal of chemical information and modeling 49 (1), 97-107, 2009 | 31 | 2009 |
Jose L. Medina-FrancoUniversidad Nacional Autonoma de Mexico (UNAM)在 unam.mx 的电子邮件经过验证
